+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

From
From
From
From
From
Immunotherapy Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Immunotherapy Drugs Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
CRF1 Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

CRF1 Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
From
Cancer Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cancer Therapeutics Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Cancer Immunotherapy Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cancer Immunotherapy Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Cancer Cachexia Market Report and Forecast 2023-2031 - Product Thumbnail Image

Cancer Cachexia Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2024 - Product Thumbnail Image

T-cell Surface Glycoprotein CD4 - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Loading Indicator